Pfizer (MIC:PFE-RM) OCF Margin %: 18.10% (As of Mar. 2026) — 41% Below Median


What is Pfizer OCF Margin %?

Pfizer MIC:PFE-RM 74 OCF Margin % is 18.10% as of Mar. 2026, which is 41% below its 10-year median of 30.71. GuruFocus rates MIC:PFE-RM with a GF Score™ of 74/100. The stock has 5 warning signs investors should review. Among 959 Drug Manufacturers companies, Pfizer ranks better than 75.6% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Pfizer's Cash Flow from Operations for the three months ended in Mar. 2026 was $2,615.00 Mil. Pfizer's Revenue for the three months ended in Mar. 2026 was $14,450.00 Mil. Therefore, Pfizer's OCF Margin % for the quarter that ended in Mar. 2026 was 18.10%.

As of today, Pfizer's current OCF Yield % is 8.66%.

The historical rank and industry rank for Pfizer's OCF Margin % or its related term are showing as below:


During the past 13 years, the highest OCF Margin % of Pfizer was 40.08%. The lowest was 14.61%. And the median was 30.71%.

MIC:PFE-RM's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.94
* Ranked among companies with meaningful OCF Margin % only.

Pfizer OCF Margin % Related Terms

Pfizer OCF Margin % Historical Data

* Premium members only.

The historical data trend for Pfizer's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer OCF Margin % Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.08 28.93 14.61 20.03 18.70

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.03 -3.97 27.64 30.46 18.10

Pfizer OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Pfizer's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=11704/62579
=18.70 %

Pfizer's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=2615/14450
=18.10 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 18.10% mean?
Pfizer (MIC:PFE-RM) has a OCF Margin % of 18.10% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pfizer and its competitors. This is 41% below median its historical median of 30.71. Over the past decade, Pfizer's OCF Margin % has ranged from 14.61 to 40.08. According to the industry distribution chart, Pfizer ranks #234 out of 959 companies in the Drug Manufacturers industry, placing it in the top 24.4%.
Is Pfizer's OCF Margin % too high?
Pfizer's current OCF Margin % of 18.10% is 41% below median its 10-year median of 30.71. Over the past 10 years, this metric has ranged from a low of 14.61 to a high of 40.08. The Drug Manufacturers industry median OCF Margin % is 9.94. Pfizer's value of 18.10% is 82.1% above this industry median. Based on the distribution chart, Pfizer ranks #234 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Pfizer has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's OCF Margin % compare to GILD and BMY?
According to the Drug Manufacturers industry distribution chart, Pfizer ranks #234 out of 959 companies for OCF Margin %. This places Pfizer in the top 24% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Pfizer's value of 18.10% is 82.1% above this benchmark. Historically, Pfizer's own OCF Margin % has ranged from 14.61 to 40.08 over the past decade. While the company's 10-year median is 30.71 vs. the industry median of 9.94, Pfizer has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pfizer's current OCF Margin % of 18.10% is 82.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Pfizer and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pfizer's current OCF Margin % is 18.10%, which is 41% below median its own 10-year median of 30.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (MIC:PFE-RM) has a current OCF Margin % of 18.10%. The current OCF Margin % is 18.10%, which is 41% below median its 10-year median of 30.71 and 82.1% above the Drug Manufacturers industry median of 9.94. Pfizer's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Pfizer (MIC:PFE-RM), the current OCF Margin % is 18.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.